These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 29351901)

  • 1. XIAP Regulation by MNK Links MAPK and NFκB Signaling to Determine an Aggressive Breast Cancer Phenotype.
    Evans MK; Brown MC; Geradts J; Bao X; Robinson TJ; Jolly MK; Vermeulen PB; Palmer GM; Gromeier M; Levine H; Morse MA; Van Laere SJ; Devi GR
    Cancer Res; 2018 Apr; 78(7):1726-1738. PubMed ID: 29351901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammatory breast cancer tumor emboli express high levels of anti-apoptotic proteins: use of a quantitative high content and high-throughput 3D IBC spheroid assay to identify targeting strategies.
    Arora J; Sauer SJ; Tarpley M; Vermeulen P; Rypens C; Van Laere S; Williams KP; Devi GR; Dewhirst MW
    Oncotarget; 2017 Apr; 8(16):25848-25863. PubMed ID: 28460441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. X-linked inhibitor of apoptosis protein mediates tumor cell resistance to antibody-dependent cellular cytotoxicity.
    Evans MK; Sauer SJ; Nath S; Robinson TJ; Morse MA; Devi GR
    Cell Death Dis; 2016 Jan; 7(1):e2073. PubMed ID: 26821068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. X-linked inhibitor of apoptosis protein inhibits apoptosis in inflammatory breast cancer cells with acquired resistance to an ErbB1/2 tyrosine kinase inhibitor.
    Aird KM; Ghanayem RB; Peplinski S; Lyerly HK; Devi GR
    Mol Cancer Ther; 2010 May; 9(5):1432-42. PubMed ID: 20406946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trastuzumab signaling in ErbB2-overexpressing inflammatory breast cancer correlates with X-linked inhibitor of apoptosis protein expression.
    Aird KM; Ding X; Baras A; Wei J; Morse MA; Clay T; Lyerly HK; Devi GR
    Mol Cancer Ther; 2008 Jan; 7(1):38-47. PubMed ID: 18202008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The CARMA3-Bcl10-MALT1 Signalosome Drives NFκB Activation and Promotes Aggressiveness in Angiotensin II Receptor-Positive Breast Cancer.
    Ekambaram P; Lee JL; Hubel NE; Hu D; Yerneni S; Campbell PG; Pollock N; Klei LR; Concel VJ; Delekta PC; Chinnaiyan AM; Tomlins SA; Rhodes DR; Priedigkeit N; Lee AV; Oesterreich S; McAllister-Lucas LM; Lucas PC
    Cancer Res; 2018 Mar; 78(5):1225-1240. PubMed ID: 29259013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Smac mimetic Birinapant induces apoptosis and enhances TRAIL potency in inflammatory breast cancer cells in an IAP-dependent and TNF-α-independent mechanism.
    Allensworth JL; Sauer SJ; Lyerly HK; Morse MA; Devi GR
    Breast Cancer Res Treat; 2013 Jan; 137(2):359-71. PubMed ID: 23225169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of nuclear XIAP associates with cell growth and drug resistance and confers poor prognosis in breast cancer.
    Delbue D; Mendonça BS; Robaina MC; Lemos LGT; Lucena PI; Viola JPB; Magalhães LM; Crocamo S; Oliveira CAB; Teixeira FR; Maia RC; Nestal de Moraes G
    Biochim Biophys Acta Mol Cell Res; 2020 Oct; 1867(10):118761. PubMed ID: 32485270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of BMP and of TGFβ receptors downregulates expression of XIAP and TAK1 leading to lung cancer cell death.
    Augeri DJ; Langenfeld E; Castle M; Gilleran JA; Langenfeld J
    Mol Cancer; 2016 Apr; 15():27. PubMed ID: 27048361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NDRG2 suppresses proliferation, migration, invasion and epithelial-mesenchymal transition of esophageal cancer cells through regulating the AKT/XIAP signaling pathway.
    Yang CL; Zheng XL; Ye K; Ge H; Sun YN; Lu YF; Fan QX
    Int J Biochem Cell Biol; 2018 Jun; 99():43-51. PubMed ID: 29530788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Triptolide sensitizes human breast cancer cells to tumor necrosis factor‑α‑induced apoptosis by inhibiting activation of the nuclear factor‑κB pathway.
    Cheng X; Shi W; Zhao C; Zhang D; Liang P; Wang G; Lu L
    Mol Med Rep; 2016 Apr; 13(4):3257-64. PubMed ID: 26935527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. XIAP Limits Autophagic Degradation of Sox2 and Is A Therapeutic Target in Nasopharyngeal Carcinoma Stem Cells.
    Ji J; Yu Y; Li ZL; Chen MY; Deng R; Huang X; Wang GF; Zhang MX; Yang Q; Ravichandran S; Feng GK; Xu XL; Yang CL; Qiu MZ; Jiao L; Yang D; Zhu XF
    Theranostics; 2018; 8(6):1494-1510. PubMed ID: 29556337
    [No Abstract]   [Full Text] [Related]  

  • 13. XIAP over-expression is an independent poor prognostic marker in Middle Eastern breast cancer and can be targeted to induce efficient apoptosis.
    Hussain AR; Siraj AK; Ahmed M; Bu R; Pratheeshkumar P; Alrashed AM; Qadri Z; Ajarim D; Al-Dayel F; Beg S; Al-Kuraya KS
    BMC Cancer; 2017 Sep; 17(1):640. PubMed ID: 28893228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Syndecan-1 is a novel molecular marker for triple negative inflammatory breast cancer and modulates the cancer stem cell phenotype via the IL-6/STAT3, Notch and EGFR signaling pathways.
    Ibrahim SA; Gadalla R; El-Ghonaimy EA; Samir O; Mohamed HT; Hassan H; Greve B; El-Shinawi M; Mohamed MM; Götte M
    Mol Cancer; 2017 Mar; 16(1):57. PubMed ID: 28270211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platycodin D inhibits migration, invasion, and growth of MDA-MB-231 human breast cancer cells via suppression of EGFR-mediated Akt and MAPK pathways.
    Chun J; Kim YS
    Chem Biol Interact; 2013 Oct; 205(3):212-21. PubMed ID: 23867902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of the MEK/MAPK pathway is involved in bryostatin1-induced monocytic differenciation and up-regulation of X-linked inhibitor of apoptosis protein.
    Lin H; Chen C; Li X; Chen BD
    Exp Cell Res; 2002 Jan; 272(2):192-8. PubMed ID: 11777344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. XIAP inhibition and generation of reactive oxygen species enhances TRAIL sensitivity in inflammatory breast cancer cells.
    Allensworth JL; Aird KM; Aldrich AJ; Batinic-Haberle I; Devi GR
    Mol Cancer Ther; 2012 Jul; 11(7):1518-27. PubMed ID: 22508521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MAP4K4 is a novel MAPK/ERK pathway regulator required for lung adenocarcinoma maintenance.
    Gao X; Chen G; Gao C; Zhang DH; Kuan SF; Stabile LP; Liu G; Hu J
    Mol Oncol; 2017 Jun; 11(6):628-639. PubMed ID: 28306189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Siva1 is a XIAP-interacting protein that balances NFkappaB and JNK signalling to promote apoptosis.
    Resch U; Schichl YM; Winsauer G; Gudi R; Prasad K; de Martin R
    J Cell Sci; 2009 Aug; 122(Pt 15):2651-61. PubMed ID: 19584092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NF-kappaB activation in inflammatory breast cancer is associated with oestrogen receptor downregulation, secondary to EGFR and/or ErbB2 overexpression and MAPK hyperactivation.
    Van Laere SJ; Van der Auwera I; Van den Eynden GG; van Dam P; Van Marck EA; Vermeulen PB; Dirix LY
    Br J Cancer; 2007 Sep; 97(5):659-69. PubMed ID: 17700572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.